0.9965
price up icon1.16%   0.0114
 
loading

Xortx Therapeutics Inc (XRTX) 最新ニュース

pulisher
Jan 21, 2025

XORTX Therapeutics Appoints New Auditor to Enhance Financial Oversight - TipRanks

Jan 21, 2025
pulisher
Jan 20, 2025

XORTX Therapeutics Announces Auditor Transition - MSN

Jan 20, 2025
pulisher
Jan 18, 2025

XORTX Announces Change of Auditor - GlobeNewswire

Jan 18, 2025
pulisher
Jan 17, 2025

XORTX Therapeutics Announces Auditor Change to Davidson & Company LLP - StockTitan

Jan 17, 2025
pulisher
Jan 06, 2025

XORTX Therapeutics Expands Pipeline with Late-Stage Gout Program - TipRanks

Jan 06, 2025
pulisher
Jan 06, 2025

XORTX Adds Late Stage Gout Program to Pipeline - GlobeNewswire

Jan 06, 2025
pulisher
Jan 06, 2025

XORTX Launches XRx-026 Program for Allopurinol-Intolerant Gout Patients, Targets FDA Approval - StockTitan

Jan 06, 2025
pulisher
Dec 19, 2024

XORTX appoints finance veteran as its new CFO - MSN

Dec 19, 2024
pulisher
Dec 19, 2024

XORTX Therapeutics Welcomes New CFO Dr. Bumby - TipRanks

Dec 19, 2024
pulisher
Dec 19, 2024

XORTX Strengthens Executive Team - The Manila Times

Dec 19, 2024
pulisher
Dec 19, 2024

XORTX Therapeutics Taps Former Eli Lilly Veteran Dr. Michael Bumby as New CFO - StockTitan

Dec 19, 2024
pulisher
Dec 12, 2024

XORTX Therapeutics Unveils New Kidney Disease Discoveries - TipRanks

Dec 12, 2024
pulisher
Dec 12, 2024

XORTX Announces Presentation at the Rare and Genetic Disease Summit - GlobeNewswire

Dec 12, 2024
pulisher
Dec 12, 2024

XORTX Therapeutics Unveils Breakthrough ADPKD Research: Genetic Factors Key to Disease Progression - StockTitan

Dec 12, 2024
pulisher
Nov 15, 2024

XORTX Therapeutics Inc. Faces Financial Challenges - TipRanks

Nov 15, 2024
pulisher
Nov 15, 2024

XORTX Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 15, 2024
pulisher
Oct 24, 2024

XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024 - sharewise

Oct 24, 2024
pulisher
Oct 24, 2024

XORTX Highlights Kidney Disease Study at ASN - TipRanks

Oct 24, 2024
pulisher
Oct 18, 2024

XORTX Secures $1.5 Million in Latest Offering - TipRanks

Oct 18, 2024
pulisher
Oct 18, 2024

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement - GlobeNewswire

Oct 18, 2024
pulisher
Oct 17, 2024

XORTX Therapeutics stock falls after pricing $1.5M capital raise - MSN

Oct 17, 2024
pulisher
Oct 17, 2024

XORTX Therapeutics Announces $1.5 Million Offering - TipRanks

Oct 17, 2024
pulisher
Oct 17, 2024

XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement - GlobeNewswire

Oct 17, 2024
pulisher
Oct 16, 2024

The Significance of Moving Averages in XORTX Therapeutics Inc Inc. (XRTX) Price Performance - The InvestChronicle

Oct 16, 2024
pulisher
Oct 09, 2024

XORTX Therapeutics Advances Precision Kidney Care - TipRanks

Oct 09, 2024
pulisher
Oct 09, 2024

XORTX Initiates Precision Medicine Program - GlobeNewswire

Oct 09, 2024
pulisher
Oct 09, 2024

XORTX Therapeutics Inc. Initiates Precision Medicine Program - Marketscreener.com

Oct 09, 2024
pulisher
Oct 08, 2024

S&P 500 Financials [Sector] (SRFI) QuotePress Release - The Globe and Mail

Oct 08, 2024
pulisher
Oct 02, 2024

TSX 60 Shariah Index (TXSI) QuotePress Release - The Globe and Mail

Oct 02, 2024
pulisher
Sep 27, 2024

XORTX Therapeutics (NASDAQ:XRTX) Stock Quotes, Forecast and News Summary - Benzinga

Sep 27, 2024
pulisher
Sep 24, 2024

SEC Form 424B3 filed by XORTX Therapeutics Inc. - Quantisnow

Sep 24, 2024
pulisher
Sep 24, 2024

Form 424B3 XORTX Therapeutics Inc. - StreetInsider.com

Sep 24, 2024
pulisher
Sep 13, 2024

XORTX Therapeutics Shareholders Approve Key Decisions - TipRanks

Sep 13, 2024
pulisher
Sep 13, 2024

XORTX Announces Results of Annual and Special Meeting of Shareholders - GlobeNewswire

Sep 13, 2024
pulisher
Sep 13, 2024

XORTX Announces Results of Annual and Special Meeting of Shareholders | XRTX Stock News - StockTitan

Sep 13, 2024
pulisher
Sep 12, 2024

Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail

Sep 12, 2024
pulisher
Sep 12, 2024

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A - GlobeNewswire

Sep 12, 2024
pulisher
Sep 12, 2024

S&P 500 Index (INX) QuotePress Release - The Globe and Mail

Sep 12, 2024
pulisher
Sep 12, 2024

Ford Motor Company (F-N) QuotePress Release - The Globe and Mail

Sep 12, 2024
pulisher
Sep 12, 2024

S&P 500 Communication Services [Sector] (SRTS) QuotePress Release - The Globe and Mail

Sep 12, 2024
pulisher
Sep 12, 2024

Dow Jones Industrials Average (DOWI) QuotePress Release - The Globe and Mail

Sep 12, 2024
pulisher
Sep 07, 2024

XORTX Prepares for Shareholders’ Vote on Key Resolutions - TipRanks

Sep 07, 2024
pulisher
Sep 06, 2024

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders - GlobeNewswire

Sep 06, 2024
$21.36
price down icon 1.88%
$72.65
price down icon 0.68%
$23.34
price up icon 5.20%
$370.48
price up icon 0.61%
biotechnology ONC
$215.60
price down icon 1.09%
$116.42
price down icon 0.66%
大文字化:     |  ボリューム (24 時間):